Current Merck & Co Inc (Derivatives) (MRK) token data: Price $ 149.33, Trading Volume $ 149.67K, Market Cap $ 0.00, Circ. Supply , Total Supply . Official links to websites, social networks and documents.

Merck stock is steady after a double catalyst: first positive Phase 3 data for an mRNA melanoma ther

August has been a great month for the shares of Merck & Co., Inc. (NYSE:MRK) and Moderna Inc. (NASDAQ:MRNA), to say the least. The former’s stock closed 12.6% higher and the latter’s stock closed 176% higher on August 19th. The stocks surged after a major announcement from Moderna Inc. (NASDAQ:MRNA) shared the results from its […]

Merck stock is getting attention after new melanoma trial data, while the shares trade near a $368.9

Washington Trust Bank reduced its position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 13.4% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 114,877 shares of the company

Thornburg Investment Management Inc. raised its holdings in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 1.6% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,787,976 shares of the compa

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC cut its holdings in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 4.3% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 19,547,171 sha

Benjamin Edwards Inc. aumentó sus participaciones en Merck & Co., Inc. (NYSE:MRK - Free Report) en un 36,3% durante el segundo trimestre, según su presentación más reciente ante la Comisión de Bolsa y Valores (SEC). El fondo poseía 224.529 acciones de la empresa.

Alyeska Investment Group L.P. aumentó su posición en Merck & Co., Inc. (NYSE:MRK - Free Report) en un 7,6% durante el segundo trimestre, según la compañía en su divulgación más reciente ante la Comisión de Bolsa y Valores. La empresa poseía 2.480.590 acciones de la empresa.

Datos actuales del token de Merck & Co Inc (derivados) (MRK): precio frente al yen japonés (JPY): ¥ 23 693, volumen de operaciones 36,36 millones, capitalización de mercado N/A.

Current Merck & Co Inc (Derivatives) (MRK) token data: Price to Chinese Yuan (CNY) - CN¥ 1,012, Trading Volume 506.24K, Market Cap N/A.

Datos actuales del token de Merck & Co Inc (Derivados) (MRK): Precio a Dong vietnamita (VND) - ₫ 3.867.132, Volumen de operaciones 5,93 mil millones, Capitalización de mercado N/A.

Wellington Management Group LLP grew its stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 2.3% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 86,249,283 shares of the company

Van ECK Associates Corp lessened its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 23.6% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,370,439 shares of the company

New Mexico Educational Retirement Board boosted its position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 7.8% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 123,486 shares of the company

Royal London Asset Management Ltd. raised its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 3.1% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,987,037 shares of the company

Ferguson Wellman Capital Management Inc. lessened its holdings in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 2.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 376,644 shares of the company

Braun Stacey Associates Inc. grew its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 10.9% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 272,942 shares of the company